Manchester Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Manchester Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-171	Closed	-$3K	–	1044
2022 Q2	$3K	Sell	171 -29	-15%	-$443	﹤0.01%	667
2022 Q1	$3K	Buy	200 +150	+300%	+$2.28K	﹤0.01%	788
2021 Q4	$1K	Buy	+50	New	+$658	﹤0.01%	995

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Manchester Capital Management's NPTN Position: Q3 2022 in Review

Manchester Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 171 shares — an estimated $3K sold.

Manchester Capital Management first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Manchester Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Manchester Capital Management sold 171 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3K.
Manchester Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
Manchester Capital Management's NEOPHOTONICS CORP position peaked at $3K in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Manchester Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.